Plain-English translation of NCT07361302 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called can help people recover better from an acute stroke when given more than 4.5 hours after the stroke started. works by dissolving blood clots in the brain. Currently, this medication is only used within 4.5 hours of a stroke, so this study explores whether it could help patients who arrive at the hospital later.
Most stroke patients who arrive at the hospital more than 4.5 hours after their stroke don't have access to clot-dissolving treatments, even though brain tissue may still be salvageable. This trial aims to find out if this medication could safely expand treatment options for these patients who currently have limited options.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either as a single injection into your vein, or standard stroke care. You would stay in the hospital for about one week, then return for 7 clinical visits over approximately 3 months to track your recovery. Your doctors will regularly assess your ability to perform daily activities and watch for any side effects; the last two visits can be done from home.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Argentina